Clinical Trial Update: Series Studies of Bipolar Disorder-Valproate add-on Memantine [Phase 2, Phase 3]

View source ↗

Summary

A series of Phase 2 and Phase 3 trials evaluated memantine added to valproate for bipolar disorder, with the studies now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Memantine (memantine)
• Valproate (valproate)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Bipolar Disorders | Phase 2, Phase 3 | Status: COMPLETED